🇺🇸 Actigall in United States

FDA authorised Actigall on 31 December 1987

Marketing authorisations

FDA — authorised 31 December 1987

  • Application: NDA019594
  • Marketing authorisation holder: TEVA BRANDED PHARM
  • Local brand name: ACTIGALL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 31 December 1987

  • Marketing authorisation holder: ACTAVIS LABS UT INC
  • Status: approved

FDA — authorised 14 March 2000

  • Application: ANDA075517
  • Marketing authorisation holder: EPIC PHARMA
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 25 May 2000

  • Application: ANDA075592
  • Marketing authorisation holder: TEVA PHARMS
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 13 May 2009

  • Application: ANDA079184
  • Marketing authorisation holder: TEVA PHARMS USA
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 17 February 2010

  • Application: ANDA090530
  • Marketing authorisation holder: QUAGEN
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 12 July 2011

  • Application: ANDA090801
  • Marketing authorisation holder: GLENMARK PHARMS LTD
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 23 December 2011

  • Application: ANDA200826
  • Marketing authorisation holder: IMPAX LABS INC
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 14 February 2013

  • Application: ANDA202540
  • Marketing authorisation holder: PH HEALTH
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 17 May 2018

  • Application: ANDA210707
  • Marketing authorisation holder: ABHAI LLC
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 30 October 2018

  • Application: ANDA211145
  • Marketing authorisation holder: ZYDUS LIFESCIENCES
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 30 October 2019

  • Application: ANDA212452
  • Marketing authorisation holder: HIBROW HLTHCARE
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 12 February 2020

  • Application: ANDA213200
  • Marketing authorisation holder: RISING
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 8 May 2020

  • Application: ANDA205789
  • Marketing authorisation holder: LGM PHARMA
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 17 August 2020

  • Application: ANDA213555
  • Marketing authorisation holder: CHARTWELL RX
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 August 2020

  • Application: ANDA213504
  • Marketing authorisation holder: STRIDES PHARMA
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 22 January 2021

  • Application: ANDA210344
  • Marketing authorisation holder: STRIDES PHARMA
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 28 July 2021

  • Application: ANDA214329
  • Marketing authorisation holder: RK PHARMA
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 28 November 2022

  • Application: ANDA214849
  • Marketing authorisation holder: AUROBINDO PHARMA LTD
  • Local brand name: URSODIOL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 14 August 2024

  • Application: ANDA214717
  • Marketing authorisation holder: EPIC PHARMA LLC
  • Local brand name: URSODIOL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Actigall in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Actigall approved in United States?

Yes. FDA authorised it on 31 December 1987; FDA authorised it on 31 December 1987; FDA authorised it on 14 March 2000.

Who is the marketing authorisation holder for Actigall in United States?

TEVA BRANDED PHARM holds the US marketing authorisation.